1. Home
  2. FCF vs EVO Comparison

FCF vs EVO Comparison

Compare FCF & EVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FCF
  • EVO
  • Stock Information
  • Founded
  • FCF 1934
  • EVO 1993
  • Country
  • FCF United States
  • EVO Germany
  • Employees
  • FCF N/A
  • EVO N/A
  • Industry
  • FCF Major Banks
  • EVO Biotechnology: Pharmaceutical Preparations
  • Sector
  • FCF Finance
  • EVO Health Care
  • Exchange
  • FCF Nasdaq
  • EVO Nasdaq
  • Market Cap
  • FCF 1.7B
  • EVO 1.6B
  • IPO Year
  • FCF N/A
  • EVO 2021
  • Fundamental
  • Price
  • FCF $16.74
  • EVO $4.46
  • Analyst Decision
  • FCF Hold
  • EVO Buy
  • Analyst Count
  • FCF 5
  • EVO 2
  • Target Price
  • FCF $17.70
  • EVO $5.90
  • AVG Volume (30 Days)
  • FCF 525.5K
  • EVO 219.6K
  • Earning Date
  • FCF 01-28-2025
  • EVO 11-06-2024
  • Dividend Yield
  • FCF 3.11%
  • EVO N/A
  • EPS Growth
  • FCF N/A
  • EVO N/A
  • EPS
  • FCF 1.48
  • EVO N/A
  • Revenue
  • FCF $456,467,000.00
  • EVO $866,665,179.00
  • Revenue This Year
  • FCF N/A
  • EVO $4.56
  • Revenue Next Year
  • FCF $2.11
  • EVO $13.44
  • P/E Ratio
  • FCF $11.31
  • EVO N/A
  • Revenue Growth
  • FCF 1.76
  • EVO N/A
  • 52 Week Low
  • FCF $12.41
  • EVO $2.85
  • 52 Week High
  • FCF $19.96
  • EVO $10.09
  • Technical
  • Relative Strength Index (RSI)
  • FCF 35.20
  • EVO 48.63
  • Support Level
  • FCF $16.69
  • EVO $4.15
  • Resistance Level
  • FCF $17.14
  • EVO $5.10
  • Average True Range (ATR)
  • FCF 0.49
  • EVO 0.23
  • MACD
  • FCF -0.10
  • EVO -0.05
  • Stochastic Oscillator
  • FCF 20.48
  • EVO 32.63

About FCF First Commonwealth Financial Corporation

First Commonwealth Financial Corp functions in the financial services sector in the United States. Through its subsidiary, it offers a range of consumer and commercial banking services such as personal checking accounts, interest-earning checking accounts, savings accounts, insured money market accounts, investment certificates, fixed & variable rate certificates of deposit, and various kinds of loans. It also provides trust and wealth management services and offers insurance products. The company earns the majority of its revenue through net interest income.

About EVO Evotec SE

Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations. The company offers services in a variety of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's health. The shared R&D segment, roughly 80% of sales, provides drug discovery and manufacturing services on a typical fee-for-service basis and integrated drug discovery collaborations based on its proprietary, internally developed assets. The Just-Evotec Biologics segment, about 20% of sales, offers CDMO services for biologics. As of 2023, the company has over 5,000 employees and 18 production sites mainly in Europe and the United States.

Share on Social Networks: